Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ontak in metastatic pancreatic cancer
NCT00726037Phase 2Terminated
- Sponsor
- Loyola University Chicago
- Start
- Oct 2008
- Primary completion
- Jan 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of denileukin diftitox in pancreatic cancer (PC), sponsored by Loyola University Chicago. Started Oct 2008; status: terminated.
02
Drugs
denileukin diftitox
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00726037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00726037.